µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, µ¿¹° À¯Çüº°, Á¦Á¦º°, Áö¿ªº°
Veterinary Drugs Compounding Market, By Drug Class, By Animal Type, By Formulation, By Geography
»óǰÄÚµå : 1673863
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀåÀº 2025³â 22¾ï 9,000¸¸ ´Þ·¯, 2032³â¿¡´Â 42¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 9.1%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 22¾ï 9,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 9.10% 2032³â °¡Ä¡ ¿¹Ãø 42¾ï 2,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå Á¡À¯À²(%)
Veterinary Drugs Compounding Market-IMG1

µ¿¹°ÀǾàǰÀº °³º° µ¿¹° ȯÀÚÀÇ Çʿ信 µû¶ó ¸ÂÃãÇüÀ¸·Î ¾à¹°À» Á¶Á¦ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á µ¿¹°ÀÇ·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À̵éÀº FDA°¡ ½ÂÀÎÇÑ ÀǾàǰÀÌ È¯ÀÚ¿¡°Ô ÇÊ¿äÇÑ ÀûÀýÇÑ °­µµ¿Í ¿ë·®À¸·Î Á¸ÀçÇÏÁö ¾ÊÀ» ¶§ °¡Àå ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¹èÇÕÁ¦¸¦ ÅëÇØ ¼öÀÇ»ç´Â ¹Ý·Áµ¿¹°ÀÇ Ã¼°Ý, ³ªÀÌ, º´·Â µîÀÇ ¿äÀο¡ µû¶ó ¸ÂÃãÇü ¾à¹°°ú ¿ë·®À» ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾à¼ö󸮿¡ ´ëÇÑ À¯¿¬ÇÑ Á¢±Ù ¹æ½ÄÀº ¸¹Àº µ¿¹°ÀÇ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀåÀÇ ¼ºÀåÀº Áö³­ ¸î ³âµ¿¾È ¹Ý·Áµ¿¹° ¾çÀ°·ü Áõ°¡¿Í ¹Ý·Áµ¿¹° °ü¸®¿¡ ´ëÇÑ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° º¸È£ÀÚµé »çÀÌ¿¡¼­ ¹Ý·Áµ¿¹°¿¡°Ô ¸ÂÃãÇü ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϰíÀÚ ÇÏ´Â ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹èÇÕ ÀǾàǰ¿¡ ´ëÇÑ ±ÔÁ¦¿Í ǰÁú ±âÁØÀÇ ºÎÀç´Â ¾ÈÀü À§ÇèÀ» ÃÊ·¡ÇÏ°í ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦ÇüÀÇ ¿ë·® ¹× Á¦ÇüÀÇ À¯¿¬¼º°ú °°Àº ÀåÁ¡Àº ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³¿¡ ´ëÇÑ Ç°Áú ¸ð´ÏÅ͸µÀ» °­È­Çϱâ À§ÇÑ ÃÖ±Ù FDA ÁöħÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå, ¾àÁ¦ Ŭ·¡½ºº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå, µ¿¹° À¯Çüº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå, ó¹æº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ µ¿¹°ÀǾàǰ È­ÇÕ¹° ½ÃÀå, Áö¿ªº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Drugs Compounding Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 4.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.29 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 4.22 Bn
Figure. Veterinary Drugs Compounding Market Share (%), By Region 2025
Veterinary Drugs Compounding Market - IMG1

Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.

Market Dynamics:

Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.

Key features of the study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Veterinary Drugs Compounding Market, By Drug Class, 2020 - 2032, (USD Bn)

6. Global Veterinary Drugs Compounding Market, By Animal Type, 2020 - 2032, (USD Bn)

7. Global Veterinary Drugs Compounding Market, By Formulation, 2020 - 2032, (USD Bn)

8. Global Veterinary Drugs Compounding Market, By Region, 2020 - 2032, (USD Bn)

9. Competitive Landscape

10. Analyst Recommendation

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â